Home
CAPLIPOINT.NS

Caplin Point Laboratories Limited

NSEHealthcare
₹2,527.00
-0.44%-₹11.20 today
₹0.00₹0.00
Ask Warren
Open
₹0.00
Prev close
₹2,538.20
Day range
₹0 – ₹0
52W range
₹1,500.3 – ₹2,675
Volume
1.2L
Avg vol (20D)
2.5L
Mkt cap
₹19,292.53Cr
P/E TTM
30.2×

Trade Caplin Point Laboratories Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Company Metrics

Revenue (ttm)₹2187.19 Cr
Net Income (ttm)₹0.00
Shares Out7.60 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.19

About CAPLIPOINT.NS

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees0
Stock ExchangeNSE
Ticker SymbolCAPLIPOINT.NS
CAPLIPOINT.NS · NSE
Financial Performance

In 2026, Caplin Point Laboratories Limited's revenue was ₹2187.19 Cr, an increase of +19.00% compared to the previous year. Earnings were ₹0.00, an increase of +19.40%.

Revenue (2026)
₹2187.19 Cr
+19.00% YoY
Earnings (2026)
₹0.00
+19.40% YoY
Year-over-Year Growth
Revenue
+19.00%
Earnings
+19.40%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.